The Otsuka Group pursues an integrated pharmaceuticals model providing comprehensive health care solutions spanning from diagnostics to therapeutic treatments for a variety of disorders. Otsuka Pharmaceutical strives to create innovative drugs focusing primarily on the central nervous system and oncology, but also on a variety of other therapeutic areas including cardiovascular disorders, gastroenterology, respiratory disorders, infectious diseases and ophthalmology and dermatology. Taiho Pharmaceutical is a leading company in the area of anticancer therapy and cancer supportive care. Our parenteral nutrition business is conducted through Otsuka Pharmaceutical Factory with a view to develop this area on a global scale. The Group is recently also exploring new opportunities in medical devices with a view to developing a strategic footprint in this area.